These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2558779)

  • 1. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions.
    Unterwald EM; Tempel A; Koob GF; Zukin RS
    Brain Res; 1989 Dec; 505(1):111-8. PubMed ID: 2558779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.
    Dilts RP; Kalivas PW
    Brain Res; 1989 May; 488(1-2):311-27. PubMed ID: 2545303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sites.
    Esposito E; Cervo L; Petrillo P; Sbacchi M; Tavani A; Samanin R
    Brain Res; 1987 Dec; 436(1):25-9. PubMed ID: 2825926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE).
    Dilts RP; Kalivas PW
    Synapse; 1990; 6(2):121-32. PubMed ID: 1978419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.
    Churchill L; Dilts RP; Kalivas PW
    Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
    Spanagel R; Herz A; Shippenberg TS
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2046-50. PubMed ID: 1347943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions.
    Eghbali M; Santoro C; Paredes W; Gardner EL; Zukin RS
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6582-6. PubMed ID: 2819882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study.
    Pentney RJ; Gratton A
    Neuroscience; 1991; 45(1):95-102. PubMed ID: 1661389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of endogenous or exogenous (mu, delta) opioid peptides: relation with DA mesolimbic pathways.
    Calenco-Choukroun G; Daugé V; Féger J; Roques BP
    Prog Clin Biol Res; 1990; 328():417-20. PubMed ID: 2154801
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens.
    Spanagel R; Herz A; Shippenberg TS
    Eur J Pharmacol; 1990 Nov; 190(1-2):177-84. PubMed ID: 1981749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study.
    Waksman G; Hamel E; Delay-Goyet P; Roques BP
    Brain Res; 1987 Dec; 436(2):205-16. PubMed ID: 2829989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.